Literature DB >> 18827120

Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation.

Anita L Nelson1, Carolyn Westhoff, Sharon Myoji Schnare.   

Abstract

OBJECTIVE: The objective was to describe timely refills of hormonal contraceptive products among a large, geographically diverse population of U.S. women as an estimate of method continuation over time.
METHODS: Longitudinal prescription refills from the Verispan database were collected from 99% of retail pharmacies in the United States between October 2003 and August 2005 for specific branded hormonal contraceptives. We calculated refill rates for different contraceptive categories, for individual products, and for different age groups.
RESULTS: Refill data were available for nearly 1.7 million women for 240 days and for almost 1 million women for 420 days. After 30 days, only 59.4-75.1% of women refilled their prescriptions for the various products on a timely basis. By 3 months, only 47.7-61.2% of women returned for timely refills. By 12 months, only 16.3-34.5% of women had consistently refilled their prescriptions. Very young women had refill rates for most methods that were at least as good as those of older women.
CONCLUSION: These low rates of timely refill rates in actual practice indicate that few women had the potential for correct and consistent contraceptive use. New methods with extended cycles or a new progestin had higher rates than did other 28-day products. These high discontinuation rates suggest that barriers to successful utilization of contraceptives exist, and they highlight the need to routinely provide condoms and emergency contraception to women initiating hormonal contraception.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827120     DOI: 10.1097/AOG.0b013e3181875ec5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  14 in total

1.  Should providers give women advance provision of emergency contraceptive pills? A cost-effectiveness analysis.

Authors:  Diana G Foster; Tina R Raine; Claire Brindis; Daria P Rostovtseva; Philip D Darney
Journal:  Womens Health Issues       Date:  2010 Jul-Aug

2.  Pharmacy claims data versus patient self-report to measure contraceptive method continuation.

Authors:  Jourdan E Triebwasser; Stephanie Higgins; Gina M Secura; Qiuhong Zhao; Jeffrey F Peipert
Journal:  Contraception       Date:  2015-04-07       Impact factor: 3.375

3.  Initiation of oral contraceptives and changes in blood pressure and body mass index in healthy adolescents.

Authors:  Elyse Olshen Kharbanda; Emily D Parker; Alan R Sinaiko; Matthew F Daley; Karen L Margolis; Mary Becker; Nancy E Sherwood; David J Magid; Patrick J O'Connor
Journal:  J Pediatr       Date:  2014-09-01       Impact factor: 4.406

4.  Complications and continuation rates associated with 2 types of long-acting contraception.

Authors:  Abbey B Berenson; Alai Tan; Jacqueline M Hirth
Journal:  Am J Obstet Gynecol       Date:  2014-12-30       Impact factor: 8.661

5.  Understanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE Project.

Authors:  Meredith E Pittman; Gina M Secura; Jenifer E Allsworth; Juell B Homco; Tessa Madden; Jeffrey F Peipert
Journal:  Contraception       Date:  2010-09-17       Impact factor: 3.375

6.  Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.

Authors:  Katherine M Keyes; Keely Cheslack-Postava; Carolyn Westhoff; Christine M Heim; Michelle Haloossim; Kate Walsh; Karestan Koenen
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

7.  Using behavioral economic theory to increase use of effective contraceptives among opioid-maintained women at risk of unintended pregnancy.

Authors:  Sarah H Heil; Dennis J Hand; Stacey C Sigmon; Gary J Badger; Marjorie C Meyer; Stephen T Higgins
Journal:  Prev Med       Date:  2016-06-23       Impact factor: 4.018

8.  Measuring oral contraceptive adherence using self-report versus pharmacy claims data.

Authors:  Hallie N Nelson; Sonya Borrero; Erik Lehman; Diana L Velott; Cynthia H Chuang
Journal:  Contraception       Date:  2017-09-04       Impact factor: 3.375

9.  New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control.

Authors:  Anita Nelson
Journal:  Int J Womens Health       Date:  2010-08-09

10.  Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.

Authors:  Natasha Mack; Tineke J Crawford; Jeanne-Marie Guise; Mario Chen; Thomas W Grey; Paul J Feldblum; Laurie L Stockton; Maria F Gallo
Journal:  Cochrane Database Syst Rev       Date:  2019-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.